2LO: 2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-benzimidazole
2LO is a Ligand Of Interest in 5BT5 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
5BT5_2LO_A_505 | 8% | 14% | 0.255 | 0.736 | 2.32 | 1.58 | 10 | 9 | 5 | 0 | 100% | 1 |
4NR7_2LO_A_1204 | 91% | 40% | 0.083 | 0.968 | 1.05 | 1.3 | 3 | 4 | 0 | 0 | 100% | 0.9167 |
5BT3_2LO_A_1201 | 87% | 35% | 0.086 | 0.957 | 1.8 | 0.8 | 7 | - | 0 | 0 | 100% | 1 |
6BYA_2LO_B_201 | 81% | 62% | 0.119 | 0.971 | 0.64 | 0.8 | - | 2 | 0 | 0 | 100% | 1 |
5BT4_2LO_A_201 | 50% | 25% | 0.124 | 0.872 | 1.91 | 1.15 | 8 | 4 | 0 | 0 | 100% | 1 |
7UGL_2LO_A_1202 | 23% | 9% | 0.244 | 0.87 | 1.57 | 2.88 | 6 | 11 | 0 | 0 | 100% | 1 |